Hill January 6, 2024
Nathaniel Weixel

The Food and Drug Administration’s decision to allow Florida to import some prescription drugs from Canada marks a major shift in U.S. drug policy, and could open the door to other states looking for ways to rein in high drug prices.

The approval was three years in the making and came only after Florida sued FDA for alleged inaction. The state estimates it would save about $150 million dollars in the first year of implementation, but the plan has a long way to go before those savings are ever realized.

Still, the approval gives a political victory to both President Biden and Florida Gov. Ron DeSantis, a Republican presidential candidate, both of whom have been prioritizing lowering drug prices....

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, FDA, Govt Agencies, Pharma, Pharma / Biotech, States
FDA issues flu vaccine recommendations: 5 respiratory updates
5 Digital Health Areas To Be Impacted By The FDA Layoffs
FDA Approves First Biosimilar to Omalizumab
Trump's Nominees to Run FDA, NIH Get Greenlighted by Senate Committee
FDA Debuts a New Communications and Compliance Tool for Device Data Integrity Concerns

Share This Article